Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
The Global Therapeutic Proteins Market Report by The Business Research Company covers therapeutic proteins market drivers and restraints, therapeutic proteins market size, major players, and the impact of COVID-19 on the therapeutic proteins market.
The therapeutic proteins market consists of sales of therapeutic proteins. Therapeutic proteins provide important therapies for diseases such as diabetes, cancer, infectious diseases, hemophilia, and anemia.
Advance technologies for protein-based drug development drives the therapeutic proteins market. Therapeutic proteins cannot be synthesized chemically, they need to be produced by genetic engineering and recombinant DNA technology in living cells or organisms.
The global therapeutic proteins market is expected to grow from $90.53 billion in 2020 to $98.1 billion in 2021 at a compound annual growth rate (CAGR) of 8.4%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $155.06 billion in 2025 at a CAGR of 12.1%.
Request A Sample For The Global Therapeutic Proteins Market Report:
Some therapeutic proteins market trends are increasing approvals of monoclonal antibody drugs. Monoclonal antibodies are dominant and well-established product class in the protein therapeutic segment with more safety and immunogenicity than antibodies and treat chronic diseases such as cancer, immunological disorders.
Global therapeutic proteins market segments include:
1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone.
2) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others.
3) By Function: Enzymatic And Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics.
4) By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Therapeutic Proteins Global Market Report 2021: COVID 19 Impact and Recovery to 2030 At:
The Therapeutic Proteins Global Market Report 2021: COVID 19 Impact and Recovery to 2030 is one of a series of new reports from The Business Research Company that provides therapeutic proteins market overviews, analyzes and forecasts market size, share, therapeutic proteins market players, therapeutic proteins market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The therapeutic proteins market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Therapeutic Proteins Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.
Market Players Covered: Abbott Laboratories, Amgen Inc, Baxter International Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Pfizer Inc , Johnson & Johnson, Merck & Co., Inc, Novo Nordisk A/S, Sanofi, Biogen, Inc, Genentech, Inc, Generex Biotechnology, Genetech, Merck Serono S.A, AstraZeneca, Boehringer Ingelheim, Chugai Pharmaceutical, Diasome Pharmaceuticals, GeneScience Pharmaceuticals,, Hualan Biological Engineering, CSL Behring, Kyowa Hakko Kirin, Oramed Pharmaceuticals, Sandoz International, Teva Pharmaceutical Industries, AbbVie, Bristol Myers Squibb Co, Novartis, ProBiogen AG.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Therapeutic Proteins Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Therapeutic Proteins Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Therapeutic Proteins Global Market Report 2021:
Pharmaceutical Drugs And Biologics Logistics Market – By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
Biologics Global Market Report 2021 – By Type (Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid Cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
Reach us at:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Facebook: https://bit.ly/3lyGAlo
Follow us on Twitter: https://bit.ly/3b1rmjS